Histopathological features of ‘BRCAX’ familial breast cancers in the kConFab resource

References

• Claus E B, Schildkraut J M, Thompson W D, et al. The genetic attributable risk of breast and ovarian cancer. Cancer 1996; 77: 2318–2324
   PubMed Web of Science ®Google Scholar
• Narod S A, Foulkes W D. BRCA1 and BRCA2: 1994 and beyond. Nat Rev Cancer 2004; 4: 665–676
   PubMed Web of Science ®Google Scholar
• Thompson D, Easton D. The genetic epidemiology of breast cancer genes. J Mammary Gland Biol Neoplasia 2004; 9: 221–236
   PubMed Web of Science ®Google Scholar
• Breast Cancer Linkage Consortium. Pathology of familial breast cancer: differences between breast cancers in carriers of BRCA1 or BRCA2 mutations and sporadic cases. Lancet 1997; 349: 1505–1510
   PubMed Web of Science ®Google Scholar
• Lakhani S R, Jacquemier J, Sloane J P, et al. Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations. J Natl Cancer Inst 1998; 90: 1138–1145
   PubMedGoogle Scholar
• Lakhani S R, van de Vijver M J, Jacquemier J, et al. The pathology of familial breast cancer: predictive value of immunohistochemical markers estrogen receptor progesterone receptor, HER-2, and p53 in patients with mutations in BRCA1 and BRCA2. J Clin Oncol 2002; 20: 2310–2318
   PubMed Web of Science ®Google Scholar
• Sorlie T, Tibshirani R, Parker J, et al. Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc Natl Acad Sci USA 2003; 100: 8418–8423
   PubMed Web of Science ®Google Scholar
• Lakhani S R, Reis-Filho J S, Fulford L, et al. Prediction of BRCA1 status in patients with breast cancer using estrogen receptor and basal phenotype. Clin Cancer Res 2005; 11: 5175–5180
   PubMed Web of Science ®Google Scholar
• Foulkes W D, Stefansson I M, Chappuis P O, et al. Germline BRCA1 mutations and a basal epithelial phenotype in breast cancer. J Natl Cancer Inst 2003; 95: 1482–1485
   PubMed Web of Science ®Google Scholar
• Armes J E, Egan A JM, Southey M C, et al. The histologic phenotypes of breast carcinoma occurring before age 40 years in women with and without BRCA1 or BRCA2 germline mutations: a population-based study. Cancer 1998; 83: 2335–2345
   PubMed Web of Science ®Google Scholar
• Eisinger F, Nogues C, Guinebretiere J M, et al. Novel indications for BRCA1 screening using individual clinical and morphological features. Int J Cancer (Pred Oncol) 1999; 84: 263–267
   PubMed Web of Science ®Google Scholar
• James P A, Doherty R, Harris M, et al. Optimal selection of individuals for BRCA mutation testing: a comparison of available methods. J Clin Oncol 2006; 24: 707–715
   PubMed Web of Science ®Google Scholar
• Turner N C, Reis-Filho J S, Russell A M, et al. BRCA1 dysfunction in sporadic basal-like breast cancer. Oncogene 2007; 26: 2126–2132
   PubMed Web of Science ®Google Scholar
• Mann G J, Thorne H, Balleine R L, et al. Analysis of cancer risk and BRCA1 and BRCA2 mutation prevalence in the kConFab familial breast cancer resource. Breast Cancer Res 2006; 8: R12
   PubMed Web of Science ®Google Scholar
• National Health and Medical Research Council. Clinical Practice Guidelines. Familial Aspects of Cancer: A Guide to Clinical Practice. Commonwealth of Australia, Canberra 1999
   Google Scholar
• Elston C W, Ellis I O. Pathological prognostic factors in breast cancer. 1. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 1991; 19: 403–410
   PubMed Web of Science ®Google Scholar
• Eisinger F, Jacquemier J, Charpin C, et al. Mutations at BRCA1: the medullary breast carcinoma revisited. Cancer Res 1998; 58: 1588–1592
   PubMed Web of Science ®Google Scholar
• Lakhani S R, Gusterson B A, Jacquemier J, et al. The pathology of familial breast cancer: histological features of cancers in families not attributable to mutations in BRCA1 or BRCA2. Clin Cancer Res 2000; 6: 782–789
   PubMed Web of Science ®Google Scholar
• Eerola H, Heikkila P, Tamminen A, et al. Histopathological features of breast tumours in BRCA1, BRCA2 and mutation-negative breast cancer families. Breast Cancer Res 2005; 7: R93–100
   PubMed Web of Science ®Google Scholar
• Anderson W F, Chu K C, Chang S, et al. Comparison of age-specific incidence rate patterns for different histopathologic types of breast carcinoma. Cancer Epidemiol Biomarkers Prev 2004; 13: 1128–1135
   PubMed Web of Science ®Google Scholar
• Iau P TC, Marafie M, Ali A, et al. Are medullary breast cancers an indication for BRCA1 mutation screening? A mutation analysis of 42 cases of medullary breast cancer. Breast Cancer Res Treat 2004; 85: 81–88
   PubMed Web of Science ®Google Scholar
• Eerola H, Heikkila P, Tamminen A, et al. Relationship of patients’ age to histopathological features of breast tumours in BRCA1 and BRCA2 and mutation-negative breast cancer families. Breast Cancer Res 2005; 7: R465–R469
   PubMed Web of Science ®Google Scholar
• Vaziri S AJ, Krumroy L M, Elson P, et al. Breast tumor immunophenotype of BRCA1-mutation carriers is influenced by age at diagnosis. Clin Cancer Res 2001; 7: 1937–1945
   PubMed Web of Science ®Google Scholar
• Bertwistle D, Ashworth A. The pathology of familial breast cancer: How do the functions of BRCA1 and BRCA2 relate to breast tumour pathology?. Breast Cancer Res 1999; 1: 41–47
   PubMedGoogle Scholar
• Southey M C, Tesoriero A, Young M A, et al. A specific GFP expression assay, penetrance estimate, and histological assessment for a putative splice site mutation in BRCA1. Hum Mutat 2003; 22: 86–91
   PubMed Web of Science ®Google Scholar
• Lovelock P K, Healey S, Au W, et al. Genetic, functional, and histopathological evaluation of two C-terminal BRCA1 missense variants. J Med Genet 2006; 43: 74–83
   PubMed Web of Science ®Google Scholar
• Chenevix-Trench G, Healey S, Lakhani S, et al. Genetic and histopathologic evaluation of BRCA1 and BRCA2 DNA sequence variants of unknown clinical significance. Cancer Res 2006; 66: 2019–2027
   PubMed Web of Science ®Google Scholar
• Chen X, Truong T TN, Weaver J, et al. Intronic alterations in BRCA1 and BRCA2: effect on mRNA splicing fidelity and expression. Hum Mutat 2006; 27: 427–435
   PubMed Web of Science ®Google Scholar
• Hitchins M P, Wong J JL, Suthers G, et al. Inheritance of a cancer-associated MLH1 germ-line epimutation. New Engl J Med 2007; 356: 697–705
   PubMed Web of Science ®Google Scholar